Keywords
hemodialysis
mineral and bone disorders
How to Cite
Abstract
Background. At the turn of the 20th and 21st centuries, the world community was faced with a global problem that has not only medical, but also great social economic significance – a pandemic of chronic non-communicable diseases that annually claim millions of lives, lead to severe complications associated with disability and the need for high-cost treatment. Among them is chronic kidney disease (CKD), which occupies an important place due to its significant prevalence in the population, a sharp decrease in the quality of life, high mortality of patients, and which leads to the need for expensive methods of renal replacement therapy (RRT).
Objective: to determine the 3-year cumulative fracture rate (proportion of adults with fractures of the femur, forearm, or proximal part of the humerus) at least once during 3 years of follow-up, and the level of calcium, phosphorus, parathyroid hormone (PTH), alkaline phosphatase and vitamin D in patients who are treated with programmed hemodialysis and have long bone fractures.
Materials and Methods: To determine the 3-year cumulative fracture rate (proportion of adults with fractures of the femur, forearm, or proximal part of the humerus) at least once during the 3-year follow-up, 512 patients treated with hemodialysis for more than 3 years were observed. 50 bone fractures were diagnosed during 2019-2022 (femur – 25, tibia – 6, proximal part of the humerus – 6, forearm – 4, pelvis – 2, ribs – 2, vertebrae – 5).
Results. A more detailed study of indicators of mineral metabolism was conducted on 154 patients with CKD stage V who were treated with hemodialysis at the MNPE “Kyiv Regional Clinical Hospital” of the KCC. Subsequently, the patients were divided into 2 groups: (1) patients on hemodialysis with fractures of long bones of the skeleton (n=41: femur – 25, tibia – 6, proximal part of the humerus – 6, forearm – 4) who were treated at the regional trauma center, and (2) patients without skeletal fractures (n=118) in 2019- 2022.
Conclusions. The study showed that the 3-year cumulative fracture rate in a study of 512 patients treated with hemodialysis for more than 3 years was 9.76%. Compared with patients without fractures, patients with fractures of long bones had increased levels of phosphorus and PTH and decreased levels of calcium and vitamin D in the blood serum. The level of alkaline phosphatase in the presence of fractures was twice as high as in the group of patients without fractures (p<0.001). The data indicate that disorders of mineral metabolism are the etiological factors of fractures in patients with CKD who are treated with hemodialysis.
References
Ketteler M, Block GA, Evenepoel P et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. 2017;92(1):26–36. DOI: 10.1016/j. kint.2017.04.006.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD- MBD). Kidney Int Suppl, 7 (2017), pp. 1-59. DОІ: 10.1016/j. kisu.2017.04.001.
Alem AM, Sherrard DJ, Gillen DL et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58: 396-399.
Ball AM,Gillen DL,Sherrard D et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA. 2002; 288:3014–3018.
Maeno Y, Inaba M, Okuno S et al. Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational study. Calcif Tissue Int. 2009;85: 310–316.
Wakasugi M, Kazama JJ, Taniguchi M et al. Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Miner Metab 2013; 31:315–321.
Naylor KL, McArthur E, Leslie WD et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int 2014; 86:810–818.
Wang WJ, Chao CT, Huang YC et al. The impact of acute kidney injury with temporary dialysis on the risk of fracture. J Bone Miner Res. 2014; 29:676–678.
Abbott KC, Oglesby RJ, Hypolite IO et al. Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol. 2001;11:450–457.
Nitsch D, Mylne A, Roderick PJ et al. Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant 2009;24: 1539–1544.
Rodríguez-García M, Gómez-Alonso C, Naves-Díaz M et al. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant. 2009; 24: 239–246.
Tentori F, McCullough K, Kilpatrick RD et al. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 2014;85: 166–173.
Ferro CJ, Arnold J, Bagnall D et al. Fracture risk and mortality post-kidney transplantation. Clin Transplant 2015; 29:1004–1012.
Ditte Hansen, Jonas B. Olesen, Gunnar H. Gislason, Bo Abrahamsen, Kristine Hommel Risk of fracture in adults on renal replacement therapy: a Danish national cohort study. Nephrology Dialysis Transplantation, Volume 31, Issue 10, October 2016, Pages 1654–1662. DOI: 10.1093/ndt/gfw073.
Arneson TJ, Li S, Liu J et al. Trends in hip fracture rates in US hemodialysis patients, 1993–2010. Am J Kidney Dis 2013;62:747–754.
Nair SS, Mitani AA, Goldstein BA et al. Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2013;8: 1336–1342.
Isakova T, Cai X, Lee J, Katz R, Cauley JA, Fried LF et al. Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals. J Bone Miner Res., 31 (2016), pp. 742-748. DOI: 10.1002/jbmr.2750.
Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol, 15 (2004), pp. 2208-2218. DOI: 10.1097/01. ASN.0000133041.27682.A2.
Vorland CJ, Stremke ER, Moorthi RN et al. Effects of excessive dietary phosphorus intake on bone health. Curr Osteoporos Rep, 15 (2017), pp. 473-482. DOI: 0.1007/s11914-017-0398-4.
Mirza MA, Karlsson MK, Mellstrom D, Orwoll E, Ohlsson C, Ljunggren O et al. Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J BoneMiner Res., 26 (2011), pp. 857-864.
Carrillo-López N, Panizo S, Alonso-Montes C, Román-García P, Rodríguez I, Martínez-Salgado C et al. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int., 90 (2016), pp. 77-89. DOI: 10.1016/j.kint.2016.01.024 | Medline.
Stehman-Breen CO, Sherrard DJ, Alem AM et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 2000; 58:2200–2205.
Danese MD, Kim J, Doan QV et al. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 2006;47: 149–156.
Gonzalez-Parra E, Tuñón J, Egido J, Ortiz A. Phosphate: a stealthier killer than previously thought? Cardiovasc Pathol., 21 (2012), pp. 372-381. DOI: 10.1016/j.carpath.2012.02.008 | Medline.
Jadoul M, Albert JM, Akiba T et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int., 70 (2006), pp. 1358-1366. DOI: 10.1038/sj.ki.5001754 | Medline.
Danese MD, Kim J, Doan QV, Dylan M, Griffiths R. ChertowGM PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis., 47 (2006), pp. 149-156. DOI: 10.1053/j.ajkd.2005.09.024 | Medline.
Bover J, Ureña P, Aguilar A, Mazzaferro S, Benito S, López-Báez V et al. Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders. Calcif Tissue Int., 103 (2018), pp. 111-124.
Russo CR, Taccetti G, Caneva P, Mannarino A, Maranghi P, Ricca M. Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int., 8 (1998), pp. 443-448.
Chou FF, Chen JB, Lee CH et al. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism. Arch Surg, 136 (2001), pp. 1064-1068. DOI: 10.1001/archsurg.136.9.1064.
Maruyama Y, Taniguchi M, Kazama JJ et al. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant. 2014;29: 1532–1538. DOI: 10.1093/ndt/gfu055.
Coen G, Mantella D, Manni M et al. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int., 68 (2005), pp. 1840-1848. DOI: 10.1111/j.1523-1755.2005.00603.x | Medline.
Ambrus C, Almasi C, Berta K et al. Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol., 43 (2011), pp. 475-482. DOI: 10.1007/s11255-010-9723-x | Medline.
Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis., 60 (2012), pp. 139- 156. DOI: 10.1053/j.ajkd.2011.12.035 | Medline.
Armstrong RA, Davey T, Allsopp AJ, Lanham-New SA, Oduo- za U, Cooper JA et al. Low serum 25-hydroxyvitamin D status in the pathogenesis of stress fractures in military personnel: An evidenced link to support injury risk management. PLoS One, 15 (2020).
Piergiorgio Messa. Skeletal fractures in patients on renal replacement therapy: how large still is the knowledge gap? Nephrology Dialysis Transplantation, Volume 31, Issue 10, October 2016, Pages 1554–1556. DOI: 10.1093/ndt/gfw055.
This work is licensed under a Creative Commons Attribution 4.0 International License.